Immunotherapy of cancer by peptide-based vaccines for the induction of tumor-specific T cell immunity

This publication has 66 references indexed in Scilit:

• Differences and similarities in the A2.1‐restricted cytotoxic T cell repertoire in humans and human leukocyte antigen‐transgenic mice
  European Journal of Immunology, 1996
• The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer
  Nature Medicine, 1995
• Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.
  Journal of Clinical Investigation, 1995
• Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
  Science, 1994
• Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines
  Science, 1994
• Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1
  Nature, 1993
• Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathway
  Immunology Today, 1991
• Human papillomaviruses in the pathogenesis of anogenital cancer
  Virology, 1991
• STRUCTURE, FUNCTION, AND DIVERSITY OF CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULES
  Annual Review of Biochemistry, 1990
• Latent Papillomavirus and Recurring Genital Warts
  New England Journal of Medicine, 1985